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1. Introduction 
A tremendous diversity of ligand binding proteins exists in nature. This undoubtedly 
creates considerable opportunities for scientific and medicinal applications. In this chapter, 
we will consider a range of ligand binding proteins, with particular attention to two classes, 
namely the ligand-binding proteins of the bacterial periplasm and odorant-binding proteins, 
because these proteins are the building blocks for biosensor development. 
2. Diversity of ligand-binding proteins 
All functions of living organisms are related to proteins that are present in enormous 
numbers in the living cell. Usually, proteins are classified by their function. Often, proteins 
have a range of different functions. Interestingly, the functions of many proteins involved in 
different biological processes begin with the binding of specific molecules: carbohydrates, 
amino acids, anions, metal ions, ions, oligo-peptides, proteins, lipids, odorant molecules and 
others, collectively known as ligands. Vital cell processes, such as DNA replication, gene 
expression, cell signaling and so on, are initiated by the binding of specific ligands. 
Trafficking of molecules throughout cellular compartments is possible after the binding of 
such molecules to a specific carrier protein. To perform their biological functions, enzymes 
must bind to their cognate substrates. Though performing diverse biological functions, all of 
these proteins fall into the category of ligand-binding proteins. Such proteins include 
periplasmic binding proteins, biotin-binding proteins, lipid-binding proteins, lectins, serum 
albumins, immunoglobulins, and others (De Wolf & Brett, 2000). Given that ligand binding 
proteins have a high affinity for their ligands, ligand-binding proteins can be used in 
protein-based controlled delivery systems for bioactive compounds sensitive to 
environmental factors. Another application of ligand-binding proteins is for biosensing of 
different disease markers, pathogenic molecules, environmental toxins and chemically or 
biologically hazardous compounds. Some of these proteins do not alter their structure in 
response to ligand binding (lipid-binding proteins, lectins). By contrast, other proteins show 
significant ligand-induced conformational changes. For example, the two-lobed ligand 
binding proteins of bacterial periplasm switch from their open-form in the absence of 
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ligands to their closed-form in the presence of ligands (Stratton & Loh, 2011). In general, 
ligand-binding proteins, including lipid-binding proteins, some of the lectins, serum 
albumins and biotin-binding proteins, recognize a wide array of bound ligands. By contrast, 
there are proteins with narrow specificity (for example, most of the periplasmic binding 
proteins). Ligand-binding proteins vary in their overall structure and number of binding 
sites, but most such proteins have a complex multi-domain structure or exist as multi-mers. 
As there are excellent reviews on the aforementioned families of ligand-binding proteins, 
here, we will only briefly discuss ligand-binding proteins and their possible therapeutic and 
clinical applications. 
The biotin-binding proteins, namely, chicken egg-white avidin, bacterial streptavidin and 
newly discovered tamavidins from basidiomycete fungi, have numerous medical, biological, 
biochemical and biotechnological applications (Laitinen et al., 2006; Takakura et al., 2010; 
Wilchek et al., 2006). These tetrameric proteins, consisting of classical -barrel monomers, 
bind biotin with exceptionally high affinity. Several peptides having the consensus HPQ 
tripeptide sequence are reported to be ligands of biotin-binding proteins, though with much 
lower affinity. The diverse family of lipid-binding proteins (LBP; Banaszak et al., 1994) is 
made up of extracellular LBPs (eLBPs, which are also known as lipocalins; Grzyb et al., 
2006) and intracellular LBPs (iLBPs; Glatz et al., 2002; Haunerland & Spener, 2004). These 
low-molecular weight proteins share a remarkably similar -barrel structure, albeit with 
some differences between iLBPs and lipocalins, and are found in diverse cell types. 
Individual LBPs can bind a wide range of small hydrophobic ligands, including fatty acids 
and retinol analogs. A representative member of the lipocalins is -lactoglobulin (-LG; 
Perez & Calvo, 1995), which is shown to be a promising carrier for fatty-acids, as well as a 
protective agent for bioactive compounds and therapeutically relevant synthetic retinoid 
derivatives (Liang & Subirade, 2010; Riihimaki-Lampen et al., 2010). An extensive group of 
lipocalins are the odorant-binding proteins (OBPs) that were successfully adapted to serve 
as biosensors for dangerous substances, including polyaromatic hydrocarbons (Wei et al., 
2008). Other lipocalins, such as neutrophil gelatinase-assotiated lipocalin (NGAL; Taub et 
al., 2010; Xu & Venge, 2000), are utilized in clinical applications. Importantly, the high 
structural plasticity of the lipocalin’s binding site allows, with the aid of genetic engineering, 
the generation of artificial lipocalins with novel ligand specificities, that is, the so-called 
anticalins (Skerra, 2008). Anticalins are immunologically active molecules that bind to small 
hapten-like compounds and to large protein antigens. Compared with antibodies, they are 
small (composed of just one polypeptide chain), do not require post-translational 
modification and exhibit robust biophysical properties. Owing to these properties, anticalins 
offer many potential applications, not only as reagents for biochemical research but also as a 
new class of drugs for medical therapy. Other ligand-binding proteins, namely serum 
albumins, bind to an extremely large number of diverse ligands (more than 70), including 
fatty acids, amino acids, therapeutic drugs and inorganic ions (Fasano et al., 2005; Varshney 
et al., 2010). Serum albumins are composed of three structurally homologous domains that 
are predominantly helical (Carter & Ho, 1994). The binding sites for a variety of ligands are 
distributed among distinct locations on the protein. The main advantage of serum albumins 
for in vivo applications is their compatibility with human blood, plasma and body 
components. Currently, serum albumins are playing an increasing role in the development 
of drug-delivery systems (Kratz, 2008) and in diverse clinical applications (Caironi & 
Gattinoni, 2009). A versatile family of periplasmic binding proteins originating in the 
periplasmic space of bacteria share a characteristic two-lobed structure and traffic different 
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nutrients, such as carbohydrates, amino acids, anions, metal ions, and di- and oligo-peptides 
(Felder et al., 1999; Fukami-Kobayashi et al., 1999; Tam & Saier, 1993). The members of this 
family commonly have high specificity for their cognate ligands, though there are 
exceptions (the case of the di/oligopeptide-binding protein). Their intrinsic ability to 
undergo a significant, ligand-induced conformational change has been utilized in the 
engineering of reagentless biosensors to monitor ligand concentration (Dwyer & Hellinga, 
2004; de Lorimier et al., 2002). Members of another ubiquitous family of sugar-specific and 
cell-agglutinating proteins, the lectins, have been found in all kinds of organisms, from 
viruses to humans (Sharon & Lis, 2004). Lectins function as recognition molecules in ligand-
cell and cell-cell interactions in a variety of biological systems. Mature plant lectins are 
divided into merolectins, hololectins, chimerolectins and superlectins, according to the 
number of carbohydrate-binding domains (Liu et al., 2010). There are only one or at most 
two carbohydrate-binding domains in merolectins and hololectins, respectively. It is 
important to note that different carbohydrate-binding domains of hololectins bind either to 
the same or structurally similar sugars. Chimerolectins are fusion proteins containing one or 
more carbohydrate-binding domains and an unrelated domain. Superlectins have at least 
two carbohydrate-binding domains with specificity for structurally unrelated sugars. Plant 
lectins have a similar tertiary structure, referred to as the lectin fold. This structural motif 
consists of a characteristically elaborate jelly roll, derived from antiparallel -strands, and 
arranged as two -sheets. This fold has also been noted in animal lectins. Animal lectins can 
be divided into 12 groups based on the similarity of their primary structures, including the 
previously discovered C-type lectins (requiring Ca2+ for activity) and the galectins 
(Kilpatrick, 2002). Animal lectins are often bi-functional, with a carbohydrate-binding 
domain and an additional domain, which is responsible for the ability of animal lectins to 
bind to non-carbohydrate ligands via protein-protein, protein-lipid and protein-nucleic acid 
interactions. Furthermore, there are examples of animal lectins with a carbohydrate-binding 
domain capable of interaction with non-sugar ligands. Many studies are devoted to the anti-
tumor activity of plant lectins against a variety of malignant cells. Lectins have a high 
potential for development of antineoplastic drugs for cancer therapy and of targeted drug 
delivery systems (Liu et al., 2010; Robinson et al., 2004). Immunoglobulins, with their typical 
tetrameric organization consisting of two light and two heavy polypeptide chains, are 
indispensable in basic research and diagnostics, as they can be adapted for the binding of an 
incredible variety of ligands (Chester & Hawkins, 1995; Sundberg, 2009). Bispecific 
antibodies that are capable of simultaneous binding to two different antigens are further 
improving the prospects for clinical applications of conventional antibodies (Fitzgerald & 
Lugovskoy, 2011). Some shortcomings of antibodies, such as their lengthy timeframe and 
high cost of production, and their large size can be overcome by development of small 
single-domain antibody fragments of high stability with the unique capacity to recognize 
molecules that are inaccessible to conventional antibodies (de Marco, 2011). Several 
additional classes of ligand-binding proteins, including inactivated enzymes, penicillin-
binding proteins, immunophilins and others, further expand the possibilities for diverse 
practical applications. 
In the next sections, we will focus on two classes of ligand-binding proteins, the two-domain 
ligand-binding proteins of the bacterial periplasm and odorant-binding proteins for which 
the use as the sensitive elements in socially important biosensor systems is mostly 
elaborated. The structure, stability and possible practical applications of these proteins will 
be discussed in detail. 
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2.1 Two-domain ligand-binding proteins of bacterial periplasm 
Two-domain ligand-binding proteins of the periplasm of gram-negative bacteria (PBPs; 
Dwyer & Hellinga, 2004; Tam & Saier, 1993) constitute a large bacterial family of proteins 
serving as primary receptors for a large number of compounds. The ligands of periplasmic 
binding proteins are represented by carbohydrates such as glucose, maltose, ribose and 
arabinose; amino acids such as glutamine, leucine, valine and histidine; metal ions such as 
phosphate, sulfate, iron, zinc and nickel; di- and oligo-peptides and vitamins. Thus, they are 
involved in the active transport of the soluble molecules inside the bacterial cell. Two-
domain ligand-binding proteins are constituents of the ATP-binding cassette in which 
ligand transport across the membrane is powered by ATP hydrolysis. In general, the ATP-
binding cassette consists of two trans-membrane domains, which assist in ligand 
translocation across the inner membrane, and two nucleotide-binding domains, which 
provide the energy required for the transport process. The periplasmic binding protein is 
responsible for trafficking of its ligand across the periplasmic space and release of its ligand 
near the inner membrane. According to recent studies, the ATP-switch model for the 
transport function of the ATP-binding cassette has been proposed. In this model, the 
coupled nucleotide-binding domains switch between an ATP-dependent closed 
conformation and a nucleotide-free, open conformation to drive the translocation of ligand 
(Dawson et al., 2007; Linton, 2007). In some cases, the periplasmic binding proteins 
participate in chemotaxis toward different substances. For example, chemotaxis toward such 
attractants as some sugars (galactose, ribose and maltose) and amino acids is activated by 
interaction between a complex of defined binding proteins and attractant molecules 
recognizing specific chemoreceptors (Felder et al., 1999; Szurmant & Ordal, 2004). 
Periplasmic binding proteins are involved in bacterial intercellular communication 
processes, termed quorum sensing (Neiditch et al., 2006; Schauder & Bassler, 2001). In this 
case, binding of small molecules, the so-called autoinducers, leads to a series of chemical 
reactions that provide the bacteria with information about the cellular density of the 
surrounding environment. Some periplasmic binding proteins act as chaperones promoting 
the proper folding of denatured proteins or their fusion partners (Dalken et al., 2010; 
Richarme & Caldas, 1997).  
The molecular weight of periplasmic binding proteins ranges from 22 to 59 kDa. Despite 
significant differences in their amino acid sequences, all ligand-binding proteins share the 
same structural topology of the polypeptide chain. All of them display a secondary structure 
of the /β type that is organized at the tertiary level into two domains linked by what is 
commonly referred to as a hinge region. This hinge region is formed by two or three short 
flexible peptide segments. The protein ligand-binding site is located in the cleft between the 
two domains. The periplasmic binding proteins can interconvert through a pronounced 
(depending on the protein) bending motion around the hinge from a ligand-free open 
conformation to a ligand-bound closed conformation. Both protein domains adopt a three-
layered /β/ sandwich fold, and the distribution of β-strands between the two domains 
defines the structural subclass of the periplasmic binding protein (figure 1). One of the 
structural sub-classes (group I), includes Escherichia coli D-galactose/D-glucose-binding 
protein (GGBP; Borrok et al., 2007); and the other subclass (group II) includes Escherichia coli 
glutamine-binding protein (GlnBP; Hsiao et al., 1996; Sun et al., 1998; Fukami-Kobayashi et 
al., 1999). Both domains possess a CheY-like fold, which gave rise to the hypothesis that the 
ancestral protein for PBP family members is derived from a one-domain CheY-like protein  
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Fig. 1. Spatial pattern of PBP of group I and group II. Tertiary structures of GGBP (a) and its 
complex with glucose GGBP/Glc (b), representing group I, are shown. The residues of the Ca-
binding site are shown in green, including the loop in the protein’s C-terminal domain 
(residues 134-142; 1) and Glu 205. Calcium is represented as a yellow sphere. The structures of 
group II GlnBP (e) and its complex with glutamine GlnBP/Gln (f) are shown. In both cases, the 
ligand (glucose or glutamine) is represented as a red stick union. The structures were created 
based on PDB data (Dutta et al., 2009); PDP codes 2GBP.ent15 (Vyas et al., 1988), 2FWO.ent16 
(Borrok et al., 2007), 1GGG (Hsiao et al., 1996) and 1WDN (Sun et al., 1998) using the graphical 
software VMD (Hsin et al., 2008) and Raster 3D (Merritt & Bacon, 1977). The topology of group 
I (c) and group II (d) proteins is drawn with -strands and -helices indicated as arrows and 
cylinders, respectively. Secondary structural elements originating from a monomeric ancestral 
protein are represented in the same color (red or blue).  
through its duplication and subsequent fusion (Lewis et al., 2000). In group I, the domain's 
β-strands have a 21345 topology and have more regular organization of its secondary 
structure, while group II proteins, derived later on the evolutionary time scale, are 
characterized by a more complex topology of their β-strand distribution within each 
separate domain. The sheet topology of both domains of group II periplasmic binding 
proteins follows a 213N4 sequence, with βN becoming the first strand after crossing-over 
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from the N-terminal domain to the C-terminal domain. The group II proteins are supposed 
to have arisen from the group I proteins through the mutual dislocation of two β-strands in 
each domain from their original domain to the other: one β-strand in the first domain 
penetrates into the parallel β-sheet of the second domain, making a new anti-parallel β-
sheet, as does the β-strand of the second domain (Fukami-Kobayashi et al., 1999). It is 
interesting that GGBP has the most regular distribution of ββ repeats throughout its 
separate domains. Additionally, there are two extra -helices in each of the GGBP domains 
that are absent in all periplasmic binding proteins of group II and in some members of 
group I. Thus, the spatial structure of GGBP seems to be the closest to that of the ancestral 
periplasmic binding protein. It is worth noting that di/oligopeptide-binding proteins 
contain a third domain in addition to the two widely recognized domains of periplasmic 
binding proteins (Nickitenko et al., 1995; Sleigh et al., 1999). According to the topology of 
the -strands typical of periplasmic binding proteins, two domains of the di/oligopeptide-
binding proteins can be regarded as group II proteins. The third domain is organized into 
two hairpins that make only a few contacts with the ligand. Still, some of the periplasmic 
binding proteins do not fall into any of the two aforementioned structural groups. These 
include, for example, zinc-binding protein TroA (Lee et al., 2002) and vitamin B12-binding 
protein BtuF (Karpowich et al., 2003), wherein the protein’s N- and C-domains are linked by 
a single long helix, imposing some rigidity on the overall protein structure. These 
periplasmic binding proteins can be regarded as group III proteins. 
Many solved structures of periplasmic binding proteins, both in the presence and in the 
absence of ligand, show large-scale motion of the two domains, described as bending and 
twisting motions around two axes. The degree of the hinge-bending motion varies from 14 
to 62  for different periplasmic binding proteins (Shilton et al., 1996). The ligand-bound 
closed state of a periplasmic binding protein in complex with its ligand possesses a protein 
surface that is quite different from that observed in the open conformation of the protein. 
This difference in protein conformation is important for recognition of protein-ligand 
complexes by the trans-membrane proteins of the ATP-binding cassette (Hollenstein et al., 
2007). For a long time, these conformational changes were assumed to be triggered by ligand 
binding. Recent studies revealed that ligand-free forms of periplasmic binding proteins are 
very flexible compared to ligand-bound forms (Bucher et al., 2011; Pang et al., 2003). This 
feature is common among all proteins of the PBP family, even among proteins in group III 
(Kandt et al., 2006; Krewulak et al., 2005). The flexible apo-form of the periplasmic binding 
proteins tends to oscillate along the modes that lead from the open to closed structure. 
Further support for this concept is provided by the existence of a dynamic equilibrium 
between the open and semi-closed conformations of the apo-form of the protein as revealed 
in the case of maltose-binding protein (MBP; Bucher et al., 2011). Additionally, the fully 
closed-form of the protein in the absence of ligand is not observed. To the contrary, GlnBP, 
in its ligand-free state, cannot achieve a partially closed conformation (Bermejo et al., 2010). 
Possible reasons for this are the stability of the hinge region of GlnBP – unusual in 
periplasmic binding proteins – and/or instability of the protein’s partially closed-
unliganded conformation. Whether other members of the PBP family can adopt a semi-
closed conformation in the absence of ligand is the subject of future studies. 
Generally, the amino acids of the protein ligand-binding site have extensive specific 
interactions with their cognate ligands, resulting in a high degree of selectivity between 
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anomeric or epimeric carbohydrates, carbohydrates of different sizes or chemically similar 
anions (Bruns et al., 1997; Cuneo et al., 2009). At the same time, semi-specific ligand-binding 
takes place. This is the case for the di/oligopeptide-binding protein that binds to peptides 
ranging in size from two to nine amino acids with little discrimination between the side 
chains of the peptides (Sleigh et al., 1999). A network of strong hydrogen bonds is formed 
with the atoms of the main peptide chains, while the peptide’s side chains adapt to the 
binding pocket with the aid of water molecules that donate hydrogen bonds to them and 
shield the ligand’s charge. 
The protein family of extra-cellularly bound lipoproteins homologous to the periplasmic 
binding proteins of gram-negative bacteria exists in gram-positive bacteria, wherein such 
extra-cellular proteins are covalently bound to outer cell surface (Felder et al., 1999). The 
spatial fold typical of the two-domain ligand-binding protein has also been found in 
transcriptional regulators, such as the lac-type repressors. Many eukaryotic receptors 
contain the PBP fold as a component of multi-domain proteins, such as glutamate/glycine-
gated ion channels (for example, the ionotropic glutamate receptor GluR2), G protein-
coupled receptors (for example, calcium-sensing receptors CaSRs) and atrial natriuretic 
peptide receptors. These receptors are regulated by conformational changes of the protein’s 
extracellular domain in response to ligand binding (van den Akker, 2001; Felder et al., 1999). 
2.2 Odorant-binding proteins 
Odorant-binding proteins in vertebrates (OBPs) belong to the family of lipocalins (Flower, 
2000). Lipocalins are a functionally diverse family of small and abundant extracellular 
proteins that bind mainly hydrophobic molecules, including lipids, odorants, pheromones, 
retinoids, porphyrins, siderophores, and steroids (Akerstrom et al., 2000; Flower et al., 2000). 
These proteins have been primarily classified as transport proteins, but it is known currently 
that lipocalins are involved in many important biological processes (Grzyb et al., 2006). 
Indeed, many lipocalins have been implicated in the regulation of cell homeostasis: 
apolipoprotein D, quiescience specific protein, purpurin, alpha-1-microglobulin, and NGAL. 
Some lipocalins, such as alpha-1-microglobulin, glicodelin and others, participate in the 
regulation of the immune response (Flower, 2000). Human tear lipocalin is expressed in 
lacrimal glands of both sexes and released into tears. Human tear lipocalin binds to a broad 
array of lipophilic substances including fatty acids, fatty alcohols, phospholipids, 
glycolipids and cholesterol (Breustedt et al., 2005; Glasgow & Gasymov, 2011). Tear lipocalin 
has a high affinity for retinol, microbial and fungal siderophores and harmful lipophilic 
compounds. It is proposed that the physiological function of human tear lipocalin is to 
prevent the corneal surface from desiccating and to stabilize the tear film by binding lipids 
present in the outer layer of tears. Tear lipocalin is also produced in von Ebner’s lingual 
salivary glands, trachea, prostate, pituitary and sweat. Tear lipocalin in those tissues is 
supposed to protect epithelia by removing harmful hydrophobic molecules. In addition, tear 
lipocalin exhibits enzymatic activity such as endonuclease and cystatin-like activity 
(Glasgow & Gasymov, 2011; Redl, 2000; Yusifov et al., 2008). Tear lipocalin also provides 
anti-fungal and anti-microbial defenses by capturing siderophores (Fluckinger et al., 2004). 
Sex-specific pheromone-binding lipocalins and odorant-binding lipocalins (OBPs) are 
supposed to be associated with chemical communication and olfaction. Pheromone-binding 
lipocalins include major urinary proteins (MUPs) of male rat and mouse secreted 
predominantly in the urine and saliva (Beynon & Hurst, 2004), aphrodisin from female 
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hamsters isolated from the vaginal discharge (Briand et al., 2004) and lipocalins of boar 
saliva (Marchese et al., 1998). These proteins are believed to serve as reservoirs for 
delivering to the environments and sustained dissemination of pheromones. Chemical 
information borne by pheromones is perceived by conspecifics and invokes various 
behavior responses in them (Hurst & Beynon, 2004).  
In contrast to pheromone-binding lipocalins, OBPs are secreted in the nasal mucus of the 
oral sphere epithelia of both sexes. OBPs have been identified in a variety of species, 
including cow (Pevsner et al., 1985), pig (Dal Monte et al., 1991), rabbit (Garibotti et al., 
1997), mouse (Pes et al., 1992), rat (Lobel et al., 2002), elephant (Lazar et al., 2002) and 
human (Briand et al., 2002). The first OBPs were discovered in the nasal mucus of the cow 
and several other animals according to their ability to bind pyrazine with a low detection 
threshold (Baldaccini et al., 1986). The studies of the binding specificity of OBPs toward 
several common odorants, which were performed mostly with bovine OBP (OBPb) and pig 
OBP-I (OBPp), have revealed that OBPs can bind a broad spectrum of hydrophobic 
molecules of medium size (Herent et al., 1995). Among the ligands with the highest affinity 
for OBPs (dissociation constants in the range of 0.1-1 M) are heterocyclic derivatives, such 
as alkyl-substituted pyrazines and thiazoles, terpenoids and their derivatives, such as 
menthol and thymol, and medium size aliphatic alcohols and aldehyes (Herent et al., 1995). 
Spherically shaped terpenoids, such as camphor and its analogues, and polar compounds, 
such as the short chain fatty acids, exhibit poor affinity to OBPs. The low selectivity of OBPs 
gave rise to the hypothesis that these soluble proteins might function as chaperones for 
volatile hydrophobic odorants and pheromone molecules crossing the aqueous mucus layer 
to the olfactory receptors embedded in the membrane of olfactory neurons (Pevsner & 
Snyder, 1990; Steinbrecht, 1998). Later, it was proposed that OBPs probably play a more 
specific role in olfaction through their involvement in the first step of odorant 
discrimination. Indeed, the expression of several sub-types of OBP in the same animal 
species differing in their primary structure and having different ligand binding patterns has 
been observed in some animal species (Ganni et al., 1997; Garibotti et al., 1997; Utsumi et al., 
1999). Three rat OBPs are specially tuned for distinct chemical classes of odorant molecules 
(Löbel et al., 2002). Rat OBP-1 preferentially binds heterocyclic compounds such as pyrazine 
derivatives. Rat OBP-2 is more specific for long-chain aliphatic aldehydes and carboxylic 
acids, while OBP-3 interacts strongly with odorant molecules having a saturated or 
unsaturated ring structure (Löbel et al., 2002). Microheterogeneity of OBPs was reported in 
the pig (Scaloni et al., 2001), mouse (Utsumi et al., 1999), rabbit (Garibotti et al., 1997) and 
porcupine (Ganni et al., 1997). Recently, it was shown that post-translational modifications 
can further increase the micro-diversity of OBPs (Le Danvic et al., 2009; Nagnan-Le Meillour 
et al., 2009). Indeed, porcine OBP can be posttranslationally modified by phosphorylation, 
resulting in a set of OBPp isoforms with different binding properties (Brimau et al., 2010). 
Moreover, the binding specificity of the VEG1 isoform, an olfactory binding protein 
expressed in the vomeronasal organ of the pig, to steroids is linked to the O-N-
acetylglucosaminylation of the protein. The porcine VEG2 isoform, which does not undergo 
this modification, showed specificity for fatty acids rather than steroids (Le Danvic et al., 
2009). Thus, it is supposed that phosphorylation and glycosylation could be a mechanism of 
regulation of OBP binding properties toward odorant and pheromone ligands, and an 
expanded set of OBP isoforms can serve to preliminary discriminate among ligands prior 
binding to the olfactory receptor (Le Danvic et al., 2009; Nagnan-Le Meillour et al., 2009). 
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The similarity in the amino acid sequences of different OBPs is limited with a sequence 
homology in the range of only 21-26 %. However, few amino acid residues are absolutely 
conserved within all OBP classes as well as within the lipocalin family (Flower, 2000). They 
include a GxW motif at the N terminal element (residues 14-16; here and throughout, the 
section numeration is given according to OBPp), two cysteine residues located on the 4th 
strand -barrel and at the C terminal element, respectively (residues 63 and 155), and a Gly 
(residue 119). Cysteine residues form a disulfide bridge, thus tightening the - helix domain 
and the -barrel. The motif YxxxYxG is also highly conserved (residues 78-84). Bovine OBP 
is the only protein in the OBP class that has only two of four conserved patches, including 
GxW and the YxxxYxG motifs (Bianchet et al., 1996). Members of the lipocalin family, 
including the OBP class, share a common β-barrel structure (figure 2). The nine-stranded -
barrel comprises residues 9-120 (strands 1-8) linked by a turn in the sequence to a short -
helical domain (residues 124-141), followed by the 9th strand of the barrel (residues 146-148) 
and by a C-terminal tail (residues 149-157). The -barrel is often preceded by an N-terminal 
segment, containing a short 310-like helical moiety (residues 1-8). The barrel of OBPs is 
markedly deformed to have an elliptical shape in cross-section. The -barrel encloses a 
ligand binding site composed of both an internal cavity and an external loop scaffold. Loops 
L2-L7 connecting strands 2-8 are all typical of short -hairpins; the exception is loop L1 
between the 1st and 2nd strands, which is a large loop. Loop L1 forms a lid, partially 
closing the internal ligand-binding site at this end of the barrel. The internal ligand-binding 
cavity is formed of mainly hydrophobic and aromatic amino acids. The cavity is shielded 
from the solvent, and during the interaction of OBP with the ligand, an opening event takes 
place, allowing the ligand to enter the binding pocket (Golebiowski et al., 2007; Vincent et al., 
2004). A molecular dynamics study shows that these events occur mainly at the junction 
between the -strands and loops L1 and L5 with the Tyr-82 residue serving as a gate in the 
OBPs (Golebiowski et al., 2007). The tyrosine residue at this position is highly conserved  
 
Fig. 2. Structure of OBPp (PDB code 1A3Y, Spinelly et al., 1998) in two projections. 
Conserved patches are shown in blue, including the Y78xxxYxG84 (1), G14xW16 (2) motifs and 
Gly-119 residue. Residues Cys-63 and Cys-155 are shown as yellow stick unions. The drawing 
was generated by the graphic programs VMD (Hsin et al., 2008) and Raster3D (Merritt & 
Bacon, 1977). 
www.intechopen.com
 
Protein Structure 
 
274 
within the OBP class and tolerates substitution only with a phenylalanine residue, which 
preserves the structure of “the door”. Investigation of the crystallographic structure of OBPb 
and OBPp complexed with different ligands revealed that the orientation of the ligands 
inside the cavity appeared to be opportunistic with no specific target patches for aromatic or 
charged groups and no correlation between the number of contacts and the affinity 
measured in solution (Vincent et al., 2004). 
In contrast to classical lipocalin, dimeric bovine OBP, OBPb, is characterized by a unique 
folding pattern that involves the crossing of the -helical domain of each monomer over the 
-barrel of the other (Bianchet et al., 1996). In addition to the ligand binding site formed by 
the internal cavity of the -barrel in each monomer, OBPb has a putative third binding site 
called the “central pocket”, which is located at the dimer interface in communication with 
the solvent (Bianchet et al., 1996; Pevsner et al., 1985). The function of the central pocket is 
not well understood. It has been recently proposed that the holo-form of OBPb captures the 
first encountered odorant molecules at the central pocket irrespective of their affinity to 
OBPb (Ikematsu et al., 2005). The initial ligand binding is supposed to be a prerequisite for 
stabilization of the OBPb structure and for the adjustment of internal binding sites for 
interaction with ligands. OBPb can further bind the odorant with high affinity at its internal 
cavity, releasing the pre-bound ligand at the central odorant-binding pocket. The internal 
cavity-bound odorant can be released by the binding of other odorants at the internal cavity 
of the second OBPb subunit or at the central pocket, depending on the nature of the odorant. 
It is believed that such interactions of OBPb with its ligands make it more reactive than 
other monomeric OBPs and enable a quick recognition of a change in the environment that 
is highly desirable for ruminant animals, thus permitting them to escape from danger. 
Careful examination of the structure of OBPb and OBPp, which exhibits a classical lipocalin 
fold, revealed the presence of a single insertion of a glycine residue at the hinge between the 
-helical moiety and -barrel domain in OBPp with respect to OBPb (the stretch 
L117LGKG121TDIED126 in OBPp; Spinelli et al., 1998). The Gly-121 residue is located exactly at 
the position where domain swapping occurs in OBPb, and its presence induces a shift in the 
alignment of the structural elements joining the swappable domains. The longer and more 
flexible linker segment between the -helical and -barrel domains in OBPp is proposed to 
be sufficient for preventing domain swapping in the protein (Spinelli et al., 1998), while a 
conserved disulfide bridge between Cys-63 and Cys-155 stabilizes this non-swapped 
conformation. The fact that the mutant variant of OBPb, with an insertion of a glycine 
residue after position 121, became monomeric has further confirmed these findings (Ramoni 
et al., 2002). 
Studies of OBPs over a period of more than 20 years were not able to completely clarify their 
role. A broad range of ligands and the low number of OBPs with respect to the number of 
olfactory receptors in mammalian species argue in favor of OBP function as a non-specific 
carrier of hydrophobic molecules (Pevsner & Snyder, 1990). A role of OBPs in the 
termination of the olfactory signal has also been proposed, which entails the "removal" of 
odorants from the olfactory receptors once they have been stimulated to keep them in their 
active state. The low specificity of OBPs led to the hypothesis  that OBPs function as a 
scavenger of excess odorants to prevent olfactory receptor saturation (Burchell, 1991). 
Recent findings imply a more active role for OBPs in olfaction, which could involve the 
preliminary discrimination of odorant molecules or even a direct interaction with olfactory 
receptors. As already mentioned, the spectrum of OBPs in animal species can be expanded 
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through phosphorylation and glycosylation. Further, it has been shown with the chip based 
surface plasmon resonance technique that the OBP is able to modulate the activity of olfactory 
receptors (Vidic et al., 2008). Some evidence for subtle conformational changes in rat and 
porcine OBPs after ligand binding has been obtained in molecular dynamics studies wherein 
opening of the -strand pair was observed (Hajjar et al., 2006). These structural dynamics of 
OBPs might be essential for recognition of the OBP-ligand complex by the olfactory receptor. 
OBPs, at least in ruminants, might fulfill a protective role. The natural ligand of the bovine 
OBP, 1-octen-3-ol, which is produced by endogenous ruminal microflora of ruminants, is an 
attractant for many insect species (Ramoni et al., 2001). Thus, the OBP can be used to capture 1-
octen-3-ol and decrease the risk of infections carried by insects. OBPs have been shown to bind 
to high affinity aldehydes derived from lipid peroxidation. This observation gave rise to the 
proposal that OBPs might be used to scavenge toxic substances from nasal epithelia to protect 
them against oxidative stress (Grolli et al., 2006). 
3. Structure and stability of ligand-binding proteins 
One of the most intriguing questions in modern molecular and cell biology is how a 
globular protein folds into a unique, compact, highly organized and functionally active 
state. In the past decade, our knowledge about protein folding into the native state and even 
the notion of the native state itself has undergone considerable changes. At the turn of the 
century, publications appeared that showed that the polypeptide chains of many proteins 
could not, in principle, fold into a compact globular state. Although these proteins are 
intrinsically disordered, they are functionally active and notably are in their native state. 
These proteins form a compact globular state only upon interaction with their specific 
binding partners, such as low-molecular weight ligands, other proteins, or nucleic acids. As 
a consequence, understanding the effects of ligand binding on proteins is of great interest 
(Turoverov et al., 2010). From this point of view, ligand-binding proteins can be convenient 
models to investigate the role of the ligand in the structure and in the stabilization of 
proteins in their native state. 
3.1 The role of ligands in the process of folding and stability of two-domain ligand-
binding proteins 
The division of periplasmic binding proteins into two different structural sub-classes 
according to their structural topology makes it tempting to attribute this fact to differences 
in folding pathways of these protein sub-classes. In fact, group I proteins in general are 
characterized by simple two-state folding processes (Kashiwagi et al., 2003). More complex 
folding, accompanied by intermediate state accumulation, is observed for periplasmic 
binding proteins of group II (Chun et al., 1993; Staiano et al., 2005). For example, the folding 
of the Escherichia coli glutamine-binding protein, as studied by protein intrinsic fluorescence, 
1-anilinonaphthalene-8-sulfonic acid (ANS) emission fluorescence, far- and near-UV circular 
dichroism spectroscopy, and the parametric presentation of fluorescence data (Kuznetsova 
et al., 2004), proceeds through the formation of two intermediate states I1 and I2 (Staiano et 
al., 2005). Glutamine binding makes the GlnBP structure more resistant to the denaturing 
action of the chemical agent, guanidine hydrochloride (GdnHCl); thus, unfolding of the 
GlnBP complex with Gln (GlnBP/Gln) begins at higher GdnHCl concentrations, and the 
denaturing process becomes more cooperative. This creates the illusion of a single stage of 
GlnBP/Gln folding. However, GlnBP/Gln folding successively passes through the same 
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intermediate states as GlnBP but in a narrower range of denaturant concentrations so that 
the three stages of the folding process essentially overlap. Thus, the ligand serves as an 
agent to protect the entire protein structure from denaturation (figure 3, a – c).  
The folding mechanism for the Escherichia coli D-galactose/D-glucose-binding protein and its 
complex with glucose (GGBP/Glc), representing group I proteins, is shown to be a one-stage 
process, with GGBP/Glc being more stable to denaturation than GGBP alone (Stepanenko et 
al., 2011a). This is supported by the sigmoidal contour of all recorded characteristics, such as 
fluorescence and far- and near-CD. The linear shape of the parametrically represented 
fluorescent data and the absence of an increase in ANS fluorescence during GGBP and 
GGBP/Glc complex unfolding also argue for the lack of any intermediate states in protein 
folding (figure 3, d; Stepanenko et al., 2011a). It is noteworthy that GGBP has an extra ligand, 
the calcium ion, located at a distinct position from the glucose-binding site (Vyas et al., 1988). 
The Ca-binding site consists of the loop of the protein’s C-terminal domain (residues 134-142), 
and its structure resembles the “EF-hand” motif, which is typical of intracellular Ca-binding 
proteins (figure 1). The calcium ion forms coordination bonds with the oxygen atoms of every 
second residue of this loop and with the Glu 205 residue. The role of calcium in GGBP stability 
and folding has been evaluated. Although producing little effect on protein structure both in 
the absence and in the presence of glucose, calcium removal results in pronounced 
destabilization of GGBP even at small denaturing actions. Meanwhile, calcium depletion has 
practically no effect on GGBP/Glc stability (figure 3, d). Thus, the calcium ion serves as a 
guardian of the protein’s structure in the absence of glucose. These results indicate that the role 
of calcium consists of maintaining the native structure of GGBP in its open form. Such a 
stabilizing effect of calcium was previously observed for other calcium-containing proteins 
(Turoverov et al., 2010). Recently, the folding mechanism of GGBP has been shown to be more 
complex than expected for the folding pathways of group I proteins (Piszczek et al., 2004; 
Stepanenko et al., 2011b). An extensive analysis of the experimental data reveals that the two 
domains of GGBP have a slightly different thermal stability, which is more marked for mutant 
variants of GGBP carrying point amino acid substitutions in the ligand-binding site of the 
protein (figure 3, g – i; Stepanenko et al., 2011b). These results suggest that more careful 
interpretation of accumulated data are needed. 
While studying GdnHCl-induced unfolding – refolding of GGBP in the presence of glucose 
an interesting effect was observed (figure 3, e – f; Stepanenko et al., 2011a). The equilibrium 
curves for complex refolding-unfolding are attained only after 10 days of incubation of 
GGBP/Glc with GdnHCl. This effect is not revealed upon GGBP/Glc heating. Slow 
equilibrium acquisition between the native protein in the form of the GGBP/Glc complex 
and the unfolded state of the protein in the presence of GdnHCl is connected with increased 
viscosity of the solution at moderate and high GdnHCl concentrations, which interferes with 
diffusion of glucose molecules. Before equilibrium is established for an appreciable period 
of time, an excess concentration exists (in comparison with equilibrium) of the native 
complex (GGBP/Glc)N in the unfolding pathway or of the unfolded protein (GGBP)U in the 
refolding pathway. These imbalances are caused by the activation barrier, which must be 
overcome in both cases. In the unfolding pathway, the elementary process of complex 
dissociation does not bring about a disturbance in the configuration fit of the interacting 
GGBP and Glc molecules, so that the probability of the inverse reaction remains high. In the 
refolding pathway, (GGBP/Glc)N is formed because of the coincidence of two conditions: 
the formation of the native molecule (GGBP)N and the appearance of a configuration fit 
between (GGBP)N and Glc. Thus, the rate-limiting step in the unfolding-refolding process 
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for the GGBP/Glc complex is the disruption/tuning of the configuration fit between the 
protein in its native state and the ligand. 
 
Fig. 3. Conformational changes of GlnBP (panels a – c) and GGBP (panels d – i). GdnHCl-
induced transitions of GlnBP (blue circles) and complex with glutamine GlnBP/Gln (red 
triangles) were recorded by tryptophan fluorescence intensity at 365 nm (a, ex=297 nm), 
ANS fluorescence intensity (b) and parametric presentation of fluorescence intensities at 320 
and 365 nm (c). GdnHCl-induced transitions of GGBP (red circles) and complex with 
glucose GGBP/Glc (blue circles) and their calcium-depleted forms GGBP-Ca (pink circles) 
and GGBP-Ca/Glc (light blue circles) were characterized by equilibrium changes in 
parameter A = I320/I365, ex=297 nm (d) and parametric presentation of fluorescence 
intensities at 320 and 365 nm (inset in d). In panels a – d, data for unfolding are depicted 
with empty symbols and data for refolding, with filled symbols. Equilibration (e) of 
unfolding – refolding curves as recorded by parameter A was achieved for GGBP after an 
incubation of less than 24 h in the presence of GdnHCl (red circles) and for GGBP/Glc, only 
after an incubation of 10 days (blue circles). The renaturation (closed blue squares) and 
denaturation (open blue squares) curves for GGBP/Glc do not coincide after 24 h 
incubation, but the curves tend to approach each other. The kinetics scheme characterizes 
the GGBP and GGBP/Glc unfolding —refolding processes (f). Heat-induced denaturation of 
GGBP (red) and GGBP/Glc (blue) was recorded by differential scanning calorimetry (g) and 
by the fluorescence intensity at 365 nm (h) and the first derivative of fluorescence intensity 
(i). The deconvolution of the calorimetric traces into two separate thermal transitions in 
panel g is shown in gray. Two sequential scans (solid and dashed lines, respectively) of the 
temperature dependency of the fluorescence intensity at 365 nm of the studied proteins are 
shown to characterize the reversibility of the thermal transitions (h). 
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All of the data reveal a common effect of the ligand on the folding and stability of all 
periplasmic binding proteins. The presence of the bound ligand does not change the folding 
pattern of the individual ligand-binding protein, but makes the protein more cooperative. 
Additionally, the structure of these proteins becomes more stable to various denaturing 
actions on the binding of their cognate ligands. The protein preserves its native structure up 
to the point of ligand dissociation induced by increased denaturing effects. 
3.2 Beta-barrel scaffold of odor-binding proteins 
Investigations into heat-induced and chemical denaturation of a series of OBPs revealed 
their high structural stability. Indeed, in the case of denaturation of porcine OBPp by the 
chemical denaturing agent GdnHCl, the difference in free energy between native and 
unfolded states of OBPp is as high as –5.95 kcal/mol (Staiano et al., 2007). The native 
structure of OBPp is highly resistant to heating with a transition mid-point of approximately 
70 C (Burova et al., 1999; Paolini et al., 1999; Stepanenko et al., 2008). In the absence of 
GdnHCl, OBPp preserves some residual structure under heating up to 80 C as indicated by 
parameter A measurements (figure 4, a; Stepanenko et al., 2008). It noteworthy that 
parameter A being calculated as A = I320/I365 (where I320 and I365 are fluorescence intensities 
measured at the emission wavelengths of 320 and 365 nm, respectively), characterizes the  
 
Fig. 4. Conformational changes of OBPp.  
Heat-induced denaturation of OBPp in the absence and in the presence of different 
concentrations of GdnHCl recorded as a change in the parameter A (a). Numbers near the 
curves are GdnHCl concentrations. GdnHCl-induced conformational transitions of OBPp as 
revealed by changes in the fluorescence lifetime (green circles) and fluorescence intensities 
at 320 (red circles) and 365 (blue circles) nm (b). ex = 297 nm. The microenvironment for Trp 
16 of OBPp is shown (insert to b). Open circles represent the protein denaturation processes, 
while closed circles show the protein renaturation processes.  
shape and position of protein’s fluorescence spectra (Turoverov & Kuznetsova, 2003). 
Changes of the parameter A can provides information about even subtle perturbation of 
spatial structure of proteins. Complete temperature denaturation of the protein can be 
achieved only in the presence of GdnHCl. Aggregation of OBPp that occurs at high 
temperatures is explained as the result of increased conformational mobility of the loop 
with a loss of an ion pair connecting Glu 31 and Arg 152 (Stepanenko et al., 2008). As shown 
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by studies of the double mutant variant of OBPp with C63A and C155A substitutions, the 
conserved disulfide bridge between Cys-63 and Cys-155 plays an important role in the 
stability and function of this protein (Parisi et al., 2005). 
Interestingly, the study of GdnHCl-induced denaturation of OBPp revealed unusual 
characteristics of the fluorescence of the single Trp residue (Trp 16) in this protein (Staiano 
et al., 2007). In OBPp, the only polar group in the vicinity of Trp 16 is Lys 120. The side chain 
of Lys 120 is virtually parallel to the indole ring of Trp 16 with its positive charge located 
just over the center of the indole ring of Trp 16. This is the most favorable position for the 
formation of a complex between this group and the indole ring that could be responsible for 
the low fluorescence intensity of the native OBPp. Pre-denaturating GdnHCl concentrations 
result in an increase in the fluorescence quantum yield and a decrease in the fluorescence 
lifetime of Trp16 in OBPp (figure 4, b). These effects are not accompanied by noticeable 
changes in protein secondary and tertiary structure. The accessibility of Trp16 to the solvent 
remains unchanged, and near UV CD spectra become more pronounced, indicating 
disturbances to the microenvironment of the tryptophan residue. This likely leads to the 
disruption of the complex between Trp 16 and the positively charged NZ atom of Lys 120 
and consequently to the enhancement of fluorescence intensity. The possibility of a distance 
change between atom NZ of Lys 120 and the indole ring of the tryptophan residue of OBPp 
in water was confirmed by molecular dynamic simulations. At the same time, the increase in 
the asymmetry of the tryptophan residue microenvironment can also promote the formation 
of exciplexes of Trp 16 with bound water molecules in close vicinity to the indole ring and 
can explain the decrease in the fluorescence lifetime. Thus, pre-denaturating GdnHCl 
concentrations induce local changes in the microenvironment of Trp16 in OBPp. 
Increased stability of OBPs can be attributed to their -barrel fold. The other group of 
proteins with β-barrel topology is the family of fluorescent proteins (FPs) that are widely 
used in a variety of applications in modern biology. For FPs, an extremely high resistance to 
environmental conditions has also been observed (Stepanenko et al., 2010). 
4. Ligand-binding proteins as the sensitive element of socially important 
biosensors 
The selective interaction of ligand-binding proteins with their partners is the major 
prerequisite for their use as sensitive elements in biosensor systems for definite analytes 
(Deuchle et al., 2005). In some cases, binding of a ligand to a ligand-binding protein is 
followed by a change in total charge, refractive index or molecular mass that can be detected 
(Stratton and Loh, 2011). These approaches in vivo are complicated by a significant noise 
level, e.g., in serum blood, there are approximately 3000 proteins, and the total protein 
concentration is approximately 70 mg/mL (Tang et al., 2005). Two-domain ligand-binding 
proteins sharing the intrinsic feature of ligand-induced conformational changes and 
targeting a diversity of natural ligands have been exploited in protein engineering to 
construct different biosensor systems (Dwyer and Hellinga, 2004; Tolosa et al., 2010). The 
large protein domains motion about the hinge has been utilized to transduce the ligand 
binding event to a variety of physical signals. Though the most preferable approaches for 
analyte registration are fluorescent methods, intrinsic protein fluorescence is not suitable as 
cells and living tissues are completely impervious to UV-light. Rational introduction of 
FRET-compatible protein pairs and environmentally sensitive dyes into different sites on the 
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ligand-binding protein, as well as use of surface plasmon resonance methods, have been 
successful approaches to the design of biosensor systems (Ge et al., 2004; Khan et al., 2008, 
2010; de Lorimier et al., 2002; Okada et al., 2009; Thomas et al., 2006). Changing the affinity 
and specificity of ligand-binding proteins has been achieved by the re-engineering of the 
protein’s ligand-binding site. Much work has been performed with PBP-based biosensors 
for sugar detection (e.g., glucose, ribose and other) (Amiss et al., 2007; Medintz & 
Deschamps, 2006; Vercillo et al., 2007). Utilization of the Escherichia coli D-galactose/D-
glucose-binding protein as the sensitive element in the glucose biosensor is one of the most 
promising directions for continuous glucose monitoring (Deuchle et al., 2005; Shilton et al., 
1996). In this case, the necessity to lower the affinity of GGBP to glucose should be taken 
into account in the development of methods to monitor the glucose level in human blood 
(Amiss et al., 2007). It is worth mentioning that the ligand-binding proteins represent a 
target for the development of antimicrobial agents. These small molecules that are 
antagonists to native PBP ligands act as inhibitors of the conformational changes in proteins 
and thus block key processes in bacteria driven by PBP (Borrok et al., 2009).  
Odorant binding proteins have been proposed as promising building blocks for construction 
of optical biosensors for dangerous substances such as toxic, explosive molecules and so on. 
It has been shown that the ligand-binding site of lipocalins can be optimized to bind 
molecules that are structurally different from their cognate ligands. For example, mutant 
OBPp has been successfully utilized for the monitoring of polyaromatic hydrocarbons that 
are among the most dangerous pollutants in water and atmosphere (Wei et al., 2007).  
Thus, the construction of biosensor systems with sensors derived from ligand-binding 
proteins is one of the most promising areas in modern science. The development of an 
increasing number of such biosensor systems is dictated by the requirements of our daily 
lives, as they can be applied to the control of foodstuff quality and drug purity, 
environmental safety, detection of explosive and dangerous substances, monitoring of 
clinically relevant molecules and narcotics control (Tolosa, 2010). 
5. Conclusion 
The ligand-binding proteins, which are diverse in their structure and function, have 
numerous applications. Still, there is another way to enhance their practical importance. In 
particular, proteins from extremophilic sources, e.g., from hyperthermophilic bacteria 
(Staiano et al., 2010), could broaden the exploitation of ligand-binding proteins owing to 
their high stability under extreme conditions. In addition, ligand-binding proteins are 
convenient subjects of inquiry to elucidate one of the most intriguing and perplexing 
questions in structural and molecular biology, namely, the problem of protein folding into a 
unique, compact, highly ordered and functionally active form and, especially, the role of 
ligands in the structure and in the stabilization of proteins in their native states. 
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